<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2645286</article-id><article-id pub-id-type="doi">10.1371/annotation/6b021f46-17bd-4ffe-a378-a1b8d24a1398</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?</article-title><alt-title alt-title-type="running-head">Correction</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fleming</surname><given-names>Jo N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nash</surname><given-names>Richard A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McLeod</surname><given-names>D. O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fiorentino</surname><given-names>David F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shulman</surname><given-names>Howard M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Connolly</surname><given-names>M. Kari</given-names></name></contrib><contrib contrib-type="author"><name><surname>Molitor</surname><given-names>Jerry A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Henstorf</surname><given-names>Gretchen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lafyatis</surname><given-names>Robert</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pritchard</surname><given-names>David K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>Lawrence D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Furst</surname><given-names>Daniel E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schwartz</surname><given-names>Stephen M.</given-names></name></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>18</day><month>8</month><year>2008</year></pub-date><volume>3</volume><issue>8</issue><elocation-id>10.1371/annotation/6b021f46-17bd-4ffe-a378-a1b8d24a1398</elocation-id><copyright-statement>Public Library of Science. This is an open-access article                distributed under the terms of the Creative Commons Attribution License, which                permits unrestricted use, distribution, and reproduction in any medium, provided the                original work is properly cited.</copyright-statement><copyright-year>2008</copyright-year><related-article related-article-type="corrected-article" vol="3" page="e1452" id="N0x19d1540N0x1d2ac20" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="18197262" ext-link-type="pubmed"><article-title>Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?</article-title></related-article></article-meta></front><body><p>There was a sentence omitted from the Funding section. The complete funding information is as follows: This work was funded by the scleroderma Research Foundation that had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review and approval of the manuscript. The clinical trial of high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation and the pathology review was funded in part by award N01-AI-05419 from the National Institute of Allergy and Infectious Diseases.</p></body></article>